Overview | Agenda/Faculty Materials | IFPMA Workshop | Promotional Opportunities
Administration | Speaking Proposals | Past Conferences | Contact Us | Home


Evolving developments in the regulations applied to the pharmaceutical industry, public opinion on standards of ethical behaviour and the global economic situation make this a challenging time to be a compliance professional or legal counsel responsible for ensuring adherence to applicable laws, regulations and codes of practice within our industry.

The PCF International Pharma Congress brings together senior global compliance professionals and legal counsel from around the world to share experiences and best practices to clarify these changes and potential responses to them. In Europe, regulators are increasingly active at both national and European levels. In the USA, the newly revised PhRMA codes and the new Obama administration are beginning to have a significant impact across the pharmaceutical industry. In Asia, governments are bringing in new legislation and/or enforcing existing legislation to dispel perceptions of corruption and/or conflicts of interest within the public sector.

Keynote speakers representing the IFPMA, EFPIA, and patients will give their views on the changes affecting our industry and how pharmaceutical companies can make a real difference during these challenging times. Panel discussions will focus on transparency and international compliance. There also will be smaller track discussions on the new European Pharma Package, clinical trials in emerging markets and a selection of case study sessions. Pharmaceutical compliance leaders will share their views in a valuable open forum.

If you want to find out how to manage compliance in these challenging times, the PCF International Pharma Congress will give you the information that you need.

  • Pharmaceutical Manufacturers
  • Generic Pharmaceutical Manufacturers
  • Site Management Organizations
  • Clinical Research Organizations
  • Management Companies
  • Wholesale, Retail, Mail Order and Internet Pharmacies
  • Health Care Regulators and Policy Makers
  • Pharmaceutical and Health Care Executives and Board Members
  • Regulatory and Compliance Professionals
  • Medical Directors
  • Physicians
  • Pharmacists

  • Food and Drug Law Attorneys
  • Health Care Attorneys and In-house Counsel
  • Compliance Officers
  • Privacy Officers
  • Ethics Officers and Corporate Social Responsibility Personnel
  • Pharmaceutical Consultants
  • Investment Bankers
  • Venture Capitalists
  • Health Services Researchers and Academics
  • Auditors
  • Promotion Signatories/Approvers
  • Risk Management Personnel

Pharmaceutical Compliance Forum:

The Pharmaceutical Compliance Forum (PCF), www.PharmaComplianceForum.org, is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs. The members meet twice a year, for two days, focusing on open and informal sharing of compliance information, best practices, and current developments in the field, and sponsors a two-day international compliance congress in the Spring and a three-day US compliance congress each Fall. For membership information, contact Colleen Lacey at 215-599-6617 or via email at info@PharmaComplianceForum.org.

Brenton L. Saunders, JD, MBA (Co chair)
Special Advisor, General Atlantic, Senior Vice President and President, Consumer Health Care and Former Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation

Roeland van Aelst (Co chair)
Executive Director International, WW Office Health Care Compliance & Privacy (EMEA, Canada, Lat-Am, Asia-Pac), Johnson & Johnson

Paul B. Woods, BPharm, MA, MRPharmS (Co chair)
Global Compliance Policy Director, AstraZeneca

Ted Acosta, Esq.
Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services

Karie Jo Barwind, Esq.
Area Director Business Practices, Western Europe, Abbott Laboratories

John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP

Pierre E. Dupourque
Regional Compliance Director, Corporate Compliance, International Investigations and Programs, Pfizer Inc.

Sue Egan
Private Consultant, Former Vice President Compliance, AstraZeneca
Michael Fadus
Compliance Director, Central & Eastern Europe, Schering-Plough Corporation

Linda Horton, Esq.
Partner, Hogan & Hartson LLP

Jonathon L. Kellerman
Partner, Pharmaceutical and Life Sciences Practice, PricewaterhouseCoopers LLP

Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP

Dominique Laymand, Esq.
Senior Director Compliance & Ethics EMEA (Europe, Middle East, Turkey, Russia and Africa), Bristol-Myers Squibb

Maurits J.F. Lugard, MA, JD, LLM
Partner, Sidley Austin LLP, Former Member of the European Commission's Legal Service

Dave O'Shaunessy
Vice President and Compliance Officer, Emerging Markets & Asia Pacific, GlaxoSmithKline

Dan Ostergaard
Head of Corporate Integrity & Compliance, Novartis International AG

Maxine Nogard
International Compliance Officer, Wyeth

Michael Stephens
Senior Director, Global Ethics and Compliance, Merck

Overview | Agenda/Faculty Materials | IFPMA Workshop | Promotional Opportunities
Administration | Speaking Proposals | Past Conferences | Contact Us | Home

© Health Care Conference Administrators
Contact Webmaster